These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34502167)

  • 1. Interplay between Hepatitis E Virus and Host Cell Pattern Recognition Receptors.
    Devhare P; Madiyal M; Mukhopadhyay C; Shetty S; Shastry S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus.
    Devhare PB; Chatterjee SN; Arankalle VA; Lole KS
    PLoS One; 2013; 8(5):e63793. PubMed ID: 23671700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Capsid Protein of Hepatitis E Virus Inhibits Interferon Induction via Its N-terminal Arginine-Rich Motif.
    Lin S; Yang Y; Nan Y; Ma Z; Yang L; Zhang YJ
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31717991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Host Innate Immunity and Hepatitis E Virus.
    Li Y; Qu C; Yu P; Ou X; Pan Q; Wang W
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of SOCS3 Levels via STAT3 and Estrogen-ERαp66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.
    Sooryanarain H; Heffron CL; Mahsoub HM; Hassebroek AM; Wang B; Tian D; Ahmed SA; Meng XJ
    J Virol; 2022 Oct; 96(19):e0100822. PubMed ID: 36102649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response.
    Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q
    Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies.
    Devhare PB; Desai S; Lole KS
    Sci Rep; 2016 May; 6():26827. PubMed ID: 27230536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E virus persists in the presence of a type III interferon response.
    Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
    PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1-mediated translation inhibition.
    Pingale KD; Kanade GD; Karpe YA
    J Gen Virol; 2019 Mar; 100(3):471-483. PubMed ID: 30702423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E Virus: How It Escapes Host Innate Immunity.
    Lhomme S; Migueres M; Abravanel F; Marion O; Kamar N; Izopet J
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32731452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-λ3 as a host immune response in acute hepatitis E virus infection.
    Murata K; Kang JH; Nagashima S; Matsui T; Karino Y; Yamamoto Y; Atarashi T; Oohara M; Uebayashi M; Sakata H; Matsubayashi K; Takahashi K; Arai M; Mishiro S; Sugiyama M; Mizokami M; Okamoto H
    Cytokine; 2020 Jan; 125():154816. PubMed ID: 31465972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E virus infection activates signal regulator protein α to down-regulate type I interferon.
    Huang F; Yang C; Yu W; Bi Y; Long F; Wang J; Li Y; Jing S
    Immunol Res; 2016 Feb; 64(1):115-22. PubMed ID: 26492885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle.
    Woytinek K; Glitscher M; Hildt E
    J Virol; 2024 Jul; 98(7):e0058024. PubMed ID: 38856640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.
    Kanade GD; Pingale KD; Karpe YA
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Hepatitis E Virus Biology and Pathogenesis.
    Lin S; Zhang YJ
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E virus: from innate sensing to adaptive immune responses.
    Brüggemann Y; Klöhn M; Wedemeyer H; Steinmann E
    Nat Rev Gastroenterol Hepatol; 2024 Oct; 21(10):710-725. PubMed ID: 39039260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and determinants of chronicity in hepatitis E virus infection.
    Narayanan S; Abutaleb A; Sherman KE; Kottilil S
    J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.